INSIDERFilingvia Quantisnow
Yumanity Therapeutics Inc. logo

Yumanity Therapeutics (YMTX) executive Kenny gave up 858 shares at $2.82 to cover taxes or an exercise price

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Pauline Kenny (executive at Yumanity Therapeutics Inc., YMTX) reported that they gave up 858 shares at $2.82 to cover taxes or an exercise price on Jun 14, 2023. After these transactions the filing shows 16,948 shares held directly.

Reporting person
Kenny Pauline
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Jun 14, 2023Shares withheld for taxes or exercise price (F)Common Stock1-858$2.82$2,42016,948 direct

Holdings before and after

  • Common Stock: 17,806 to 16,948 direct

Footnotes from the filing

  1. 1. Exempt transaction pursuant to Rule 16b-3(e) for the withholding of shares of the Issuer's Common Stock by the Issuer to satisfy tax obligations relating to the acquisition of shares of the Issuer's Common Stock in connection with the settlement of the vested portion of restricted stock units.

Transaction codes in this filing

Shares withheld for taxes or exercise price:
Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.

FAQ

What did Kenny report in this YMTX Form 4?

Pauline Kenny (executive at Yumanity Therapeutics Inc., YMTX) reported that they gave up 858 shares at $2.82 to cover taxes or an exercise price on Jun 14, 2023. After these transactions the filing shows 16,948 shares held directly.

How many YMTX shares does Kenny hold after this filing?

The filing shows 16,948 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code F mean on an SEC Form 4?

Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.

Historical context for YMTX

Earlier insider filings at YMTX

Quantisnow market dataNASDAQ
Yumanity Therapeutics Inc. logo
YMTX
Yumanity Therapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2016
Get push alerts for YMTX

Follow YMTX and get a push notification the moment its next story breaks.

Full YMTX profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track YMTX (Yumanity Therapeutics Inc.) and more on Quantisnow.